Rasagiline
Links shared publicly online about this topic
Rasagiline | Medicues
medicues.com — “' Trade Name Azilect ' Generic Name RASAGILINE ' Drug Class Parkinson's Disease medication ' How It Works Medication inhibits enzyme” View full resource at medicues.com
Most Recently Shared on September 10, 2009 at 8:29 am By:
Rasagiline: · Trade Name Azilect · Generic Name RASAGILINE · Drug Class Parkinson’s Disea.. http://bit.ly/guPiS www.medicues.com
Neurology Medical News about Parkinson Disease rasagiline
mdlinx.com — “The role of rasagiline in the treatment of Parkinson's disease” View full resource at mdlinx.com
Most Recently Shared on May 17, 2010 at 8:20 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
The role of rasagiline in the treatment of Parkinson's disease: Clinical Interventions in Aging http://bit.ly/bHMcty #neurology #mdlinx
ingentaconnect Cost Effectiveness of Rasagiline and Pramipexole as Treatment Str...
ingentaconnect.com — “ingentaconnect Cost Effectiveness of Rasagiline and Pramipexole as Treatment Str...” View full resource at ingentaconnect.com
Most Recently Shared on February 2, 2011 at 11:35 pm By:
Cost Effectiveness of Rasagiline and Pramipexole as Treatment Strategies in Early Parkinsons Disease in the UK S... http://bit.ly/hf8mxe
Watson seeks FDA approval to market rasagiline mesylate tablets
news-medical.net — “Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market rasagiline mesylate 0.5 and 1.0 mg tablets.” View full resource at news-medical.net
Most Recently Shared on October 6, 2010 at 6:49 am By:
Watson seeks FDA approval to market rasagiline mesylate tablets: Watson Pharmaceuticals, Inc. today confirmed that... http://bit.ly/c4479C
Results of ADAGIO trial for rasagiline suggest possible disease-modifying effect | PD Online Research
pdonlineresearch.org — “Results of ADAGIO trial for rasagiline suggest possible disease-modifying effect | PD Online Research” View full resource at pdonlineresearch.org
Most Recently Shared on September 23, 2009 at 9:04 pm By:
PD Online Research Health Organization
Rasagiline (azilect) may have disease modifying effects for Parkinson's disease http://bit.ly/oaHl1
St. Louis University to Run Clinical Study on Rasagiline/Dopamine Agonist Combo | PD Online Research
pdonlineresearch.org — “St. Louis University to Run Clinical Study on Rasagiline/Dopamine Agonist Combo | PD Online Research” View full resource at pdonlineresearch.org
Most Recently Shared on July 13, 2010 at 1:51 pm By:
PD Online Research Health Organization
St. Louis University to Run Clinical Study on Rasagiline/Dopamine Agonist Combo http://bit.ly/bAYytk
NEJM -- A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease
content.nejm.org — “Original Article from The New England Journal of Medicine -- A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease” View full resource at content.nejm.org
Most Recently Shared on September 30, 2009 at 6:08 pm By:
Jeff Kraakevik Neurologist, Physician, and Doctor
ADAGIO -2 yr f/u for rasagiline in NEJM. Neuroprotection in PD? You look @ data and decide http://bit.ly/3Gipsc #neuroclerk
[Rasagiline: effectiveness and protection in Parki... [Rev Neurol. 2010] - PubMed result
ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 19 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on October 30, 2010 at 9:58 pm By:
[Rasagiline: effectiveness and protection in Parkinson's disease.]: CONCLUSIONS. Comparatively, rasagiline has pro... http://bit.ly/9C0eS6
5and5 Rasagiline (Azilect): 5 Risks/Side-Effects vs. 5 Benefits Analysis | Dopadoc Parkinson's International
dopadoc.com — “5and5 Rasagiline (Azilect): 5 Risks/Side-Effects vs. 5 Benefits Analysis | Dopadoc Parkinson's International” View full resource at dopadoc.com
Most Recently Shared on May 18, 2011 at 2:44 am By:
Marshall Davidson MD Doctor, Anesthesiologist, and Physician
Teva's #Azilect patents begin expiring next year 2012 http://bit.ly/iEGF3J maybe generic #rasagiline will be AS or LESS expensive than GOLD!
The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: A randomized, double-blind, placebo-controlled, multicenter study - Hanagasi - 2011 - Movement Disorders - Wiley Online Library
onlinelibrary.wiley.com — “The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: A randomized, double-blind, placebo-controlled, multicenter study - Hanagasi - 2011 - Movement Disorders - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on April 15, 2011 at 3:00 pm By:
Movement Disorders Neurology and Health Organization
The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: A randomized, ... http://bit.ly/eqBF3M
Living With Parkinson's - News in Context and Position Papers - News In Context The Michael J. Fox Foundation - From Teva's ADAGIO Trial: Inconclusive Results, but Possible Disease-modifying Effect, for Azilect (Rasagiline)
michaeljfox.org — “This week, the New England Journal of Medicine published data from the ADAGIO Phase 3 clinical trial of Israeli drugmaker Teva’s Azilect (rasagiline). The trial was designed to test whether Azilect, which is already approved for symptomatic tre...” View full resource at michaeljfox.org
Most Recently Shared on September 23, 2009 at 9:08 pm By:
michaeljfox.org Health Organization
BREAKING #PARKINSON'S NEWS: Inconclusive results from ADAGIO trial of rasagiline as disease-modifying treatment for PD http://bit.ly/8OcO4
ScienceDirect - The Lancet Neurology : A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes
sciencedirect.com — “ScienceDirect - The Lancet Neurology : A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes” View full resource at sciencedirect.com
Most Recently Shared on April 16, 2011 at 9:01 am By:
Analysis of the results of the ADAGIO study will inform us of future clinical trial design. http://t.co/NEyDoKq
Results Of ADAGIO Study With AZILECT(R) In Parkinson's Disease Published In New England Journal Of Medicine
medicalnewstoday.com — “Results from the ADAGIO trial, published online today in The New England Journal of Medicine, demonstrated that Parkinson's disease patients receiving AZILECT® (rasagiline) 1mg/day at t” View full resource at medicalnewstoday.com
Most Recently Shared on September 24, 2009 at 5:55 pm By:
MNT Parkinson's News Health News
Results Of ADAGIO Study With AZILECT(R) In Parkinson's Disease Published In New England Journal Of Medicine: Res.. http://bit.ly/jrVBZ
FDA Approves Newly Revised Prescribing Information for Azilect Reducing Medication and Food Restrictions
drugs.com — “Azilect (rasagiline) is used for Parkinson’s Disease. Information from Drugs.com includes Azilect side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on December 15, 2009 at 10:13 pm By:
FDA Approves New Prescribing Information for Azilect Reducing Medication and Food Restrictions - http://bit.ly/8BJT52
Drug Might Slow Parkinson's Disease Progression
medicalnewstoday.com — “Following one of the largest studies ever conducted in Parkinson's disease (PD), researchers at Mount Sinai School of Medicine report in The New England Journal of Medicine that rasagiline,” View full resource at medicalnewstoday.com
Most Recently Shared on September 24, 2009 at 12:48 pm By:
MNT Parkinson's News Health News
Drug Might Slow Parkinson's Disease Progression: Following one of the largest studies ever conducted in Parkinso.. http://bit.ly/va5B8
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
health-talk.com
www.health-talk.com
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Parkinson's Disease
Organizing Parkinson Disease resources shared by health experts, advocates, and organizations into WisdomCards.
Advertisement
